Deerfield Management’s CalciMedica CALC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,300,000
Closed -$8.57M 100
2025
Q4
$8.57M Hold
1,300,000
0.11% 69
2025
Q3
$4M Hold
1,300,000
0.06% 76
2025
Q2
$2.08M Hold
1,300,000
0.04% 78
2025
Q1
$2.48M Hold
1,300,000
0.05% 82
2024
Q4
$4.6M Buy
1,300,000
+300,000
+30% +$1.05M 0.09% 72
2024
Q3
$4.43M Hold
1,000,000
0.07% 71
2024
Q2
$3.96M Hold
1,000,000
0.07% 73
2024
Q1
$4.16M Buy
+1,000,000
New +$4.57M 0.07% 75
2023
Q3
Sell
-265,657
Closed -$1.07M 95
2023
Q2
$1.07M Buy
+265,657
New +$1.16M 0.02% 89
2023
Q1
Sell
-377,265
Closed -$2.64M 107
2022
Q4
$2.64M Hold
377,265
0.05% 83
2022
Q3
$4.97M Hold
377,265
0.1% 96
2022
Q2
$5.76M Hold
377,265
0.12% 91
2022
Q1
$6.5M Hold
377,265
0.15% 83
2021
Q4
$9.67M Hold
377,265
0.2% 89
2021
Q3
$17.5M Hold
377,265
0.34% 74
2021
Q2
$28.7M Hold
377,265
0.51% 62
2021
Q1
$29.3M Hold
377,265
0.62% 55
2020
Q4
$153M Hold
377,265
3.03% 5
2020
Q3
$67.1M Buy
+377,265
New +$78.7M 1.63% 17

Other funds holding CALC

Deerfield Management's CALC Position: Q1 2026 in Review

Deerfield Management sold out of CalciMedica (CALC) in Q1 2026, closing a stake of 1,300,000 shares — an estimated $8.57M sold.

Deerfield Management first reported a position in CALC in Q3 2020 and held it in 19 quarters. The position peaked at $153M in Q4 2020. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2026.

  • Deerfield Management reported no remaining CalciMedica position as of Q1 2026 after selling out during the quarter.
  • Deerfield Management sold 1,300,000 CalciMedica shares in Q1 2026, an estimated $8.57M.
  • Deerfield Management first reported a position in CalciMedica in Q3 2020 and held it in 19 quarters.
  • Deerfield Management's CalciMedica position peaked at $153M in Q4 2020.
  • 27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2026.

Based on Deerfield Management's 13F filing for Q1 2026, filed 15 May 2026.